Cardiac iron overload in transfusion-dependent patients with myelodysplastic syndromes

被引:47
作者
Roy, Noemi B. A. [1 ]
Myerson, Saul [2 ]
Schuh, Anna H. [3 ]
Bignell, Patricia [3 ]
Patel, Roger [4 ]
Wainscoat, Jim S. [5 ]
McGowan, Simon [6 ]
Marchi, Emanuele [6 ]
Atoyebi, Wale [5 ]
Littlewood, Tim [5 ]
Chacko, Joseph [7 ]
Vyas, Paresh
Killick, Sally B. [7 ]
机构
[1] John Radcliffe Hosp, Weatherall Inst Mol Med, Mol Haematol Unit, Oxford OX3 9DS, England
[2] Oxford Radcliffe Hosp, Dept Cardiol, Oxford, England
[3] Oxford Radcliffe Hosp, Haemato Mol Diagnost Serv, Oxford, England
[4] Royal Bournemouth Hosp, Dept Radiol, Bournemouth, Dorset, England
[5] Oxford Radcliffe Hosp, Dept Haematol, Oxford, England
[6] Weatherall Inst Mol Med, Computat Biol Res Grp, Oxford, England
[7] Royal Bournemouth Hosp, Dept Haematol, Bournemouth, Dorset, England
关键词
myelodysplastic syndromes; magnetic resonance imaging; transfusional iron overload; hepatic R2*; cardiac R2*; MAGNETIC-RESONANCE; MYOCARDIAL IRON; ACQUIRED ANEMIAS; THALASSEMIA; CHELATION; DISEASE;
D O I
10.1111/j.1365-2141.2011.08749.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Transfusion- dependent myelodysplastic (MDS) patients are prone to iron overload. We evaluated 43 transfused MDS patients with T2* magnetic resonance imaging scans. 81% had liver and 16.8% cardiac iron overload. Liver R2* (1000/T2*), but not cardiac R2*, was correlated with number of units transfused (r = 0.72, P < 0.0001) and ferritin (r = 0.53, P < 0.0001). The area under the curve of a time-ferritin plot was found to be much greater in patients with cardiac iron loading (median 53.7 x 10(5) Megaunits vs. 12.2 x 10(5) Megaunits, P = 0.002). HFE, HFE2, HAMP or SLC40A1 genotypes were not predictors of iron overload in these patients.
引用
收藏
页码:521 / 524
页数:4
相关论文
共 50 条
  • [21] A European survey on the detection and management of iron overload in transfusion-dependent patients with MDS
    Giagounidis, Aristoteles
    di Priolo, Susanna Leto
    Ille, Susanne
    Fenaux, Pierre
    ANNALS OF HEMATOLOGY, 2011, 90 (06) : 667 - 673
  • [22] Prospective assessment of effects on iron-overload parameters of deferasirox therapy in patients with myelodysplastic syndromes
    Greenberg, Peter L.
    Koller, Charles A.
    Cabantchik, Z. Ioav
    Warsi, Ghulam
    Glynos, Tara
    Paley, Carole
    Schiffer, Charles
    LEUKEMIA RESEARCH, 2010, 34 (12) : 1560 - 1565
  • [24] Iron overload and chelation therapy in patients with low-risk myelodysplastic syndromes with transfusion requirements
    Angel F. Remacha
    Beatriz Arrizabalaga
    Consuelo Del Cañizo
    Guillermo Sanz
    Ana Villegas
    Annals of Hematology, 2010, 89 : 147 - 154
  • [25] Iron overload and chelation therapy in patients with low-risk myelodysplastic syndromes with transfusion requirements
    Remacha, Angel F.
    Arrizabalaga, Beatriz
    Del Canizo, Consuelo
    Sanz, Guillermo
    Villegas, Ana
    ANNALS OF HEMATOLOGY, 2010, 89 (02) : 147 - 154
  • [26] Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes
    Delforge, Michel
    Selleslag, Dominik
    Beguin, Yves
    Triffet, Agnes
    Mineur, Philippe
    Theunissen, Koen
    Graux, Carlos
    Trullemans, Fabienne
    Boulet, Dominique
    Van Eygen, Koen
    Noens, Lucien
    Van Steenweghen, Steven
    Lemmens, Jan
    Pierre, Pascal
    D'hondt, Randal
    Ferrant, Augustin
    Deeren, Dries
    Van De Velde, Ann
    Wynendaele, Wim
    Andre, Marc
    De Bock, Robrecht
    Efira, Andre
    Breems, Dimitri
    Deweweire, Anne
    Geldhof, Kurt
    Pluymers, Wim
    Harrington, Amanda
    MacDonald, Karen
    Abraham, Ivo
    Ravoet, Christophe
    LEUKEMIA RESEARCH, 2014, 38 (05) : 557 - 563
  • [27] The relationship between liver stiffness by two-dimensional shear wave elastography and iron overload status in transfusion-dependent patients
    Puttawibul, Pimporn
    Kritsaneepaiboon, Supika
    Chotsampancharoen, Thirachit
    Vichitkunakorn, Polathep
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2024, 41 (06) : 409 - 421
  • [28] The deleterious effects of iron overload in patients with myelodysplastic syndromes
    Dreyfus, Francois
    BLOOD REVIEWS, 2008, 22 : S29 - S34
  • [29] Optimising management of deferasirox therapy for patients with transfusion-dependent thalassaemia and lower-risk myelodysplastic syndromes
    Kattamis, Antonis
    Aydinok, Yesim
    Taher, Ali
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (03) : 272 - 282
  • [30] OPG/RANK/RANKL axis relation to cardiac iron-overload in children with transfusion-dependent thalassemia
    Sayed, Samira Zein
    Abd El-Hafez, Asmaa Hosni
    Abu El-ela, Mostafa Ahmed
    Mourad, Mohamed Aboul-fotouh
    Mousa, Suzan Omar
    SCIENTIFIC REPORTS, 2023, 13 (01)